큐라클
1 known investors
Curacle develops first-in-class therapies aimed at restoring microvascular function in aging and chronic diseases, including small molecules via its SOLVADYS platform and biologics via its EAGLES platform. Its pipeline addresses conditions such as macular degeneration.
Investors · 1
Frequently asked questions
- What does 큐라클 do?
- Curacle develops first-in-class therapies aimed at restoring microvascular function in aging and chronic diseases, including small molecules via its SOLVADYS platform and biologics via its EAGLES platform. Its pipeline addresses conditions such as macular degeneration.
- Who are 큐라클's investors?
- 큐라클's investors include Hyundai Venture Investment Corporation.